| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.03 |